FI810981A7 - Verenpainetta alentavia amiineja. - Google Patents

Verenpainetta alentavia amiineja. Download PDF

Info

Publication number
FI810981A7
FI810981A7 FI810981A FI810981A FI810981A7 FI 810981 A7 FI810981 A7 FI 810981A7 FI 810981 A FI810981 A FI 810981A FI 810981 A FI810981 A FI 810981A FI 810981 A7 FI810981 A7 FI 810981A7
Authority
FI
Finland
Prior art keywords
amines
blood pressure
lower blood
pressure
blood
Prior art date
Application number
FI810981A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI810981L (fi
Inventor
Bernard Loev
James R Shroff
Original Assignee
Usv Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Usv Pharma Corp filed Critical Usv Pharma Corp
Publication of FI810981L publication Critical patent/FI810981L/fi
Publication of FI810981A7 publication Critical patent/FI810981A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
FI810981A 1980-04-11 1981-03-30 Verenpainetta alentavia amiineja. FI810981A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/139,367 US4258042A (en) 1980-04-11 1980-04-11 Antihypertensive pyridines and compositions

Publications (2)

Publication Number Publication Date
FI810981L FI810981L (fi) 1981-10-12
FI810981A7 true FI810981A7 (fi) 1981-10-12

Family

ID=22486280

Family Applications (1)

Application Number Title Priority Date Filing Date
FI810981A FI810981A7 (fi) 1980-04-11 1981-03-30 Verenpainetta alentavia amiineja.

Country Status (23)

Country Link
US (1) US4258042A (enExample)
JP (1) JPS56158762A (enExample)
AR (2) AR227306A1 (enExample)
AU (1) AU6941181A (enExample)
BE (1) BE888327A (enExample)
CA (1) CA1175825A (enExample)
CH (1) CH647519A5 (enExample)
DE (1) DE3109794A1 (enExample)
DK (1) DK162581A (enExample)
ES (1) ES499667A0 (enExample)
FI (1) FI810981A7 (enExample)
FR (1) FR2480284A1 (enExample)
GB (1) GB2073739B (enExample)
IL (1) IL62362A (enExample)
IT (1) IT1137539B (enExample)
LU (1) LU83293A1 (enExample)
NL (1) NL8100745A (enExample)
NO (1) NO811240L (enExample)
NZ (1) NZ196787A (enExample)
PH (1) PH15278A (enExample)
SE (1) SE8101211L (enExample)
ZA (1) ZA81802B (enExample)
ZW (1) ZW8281A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4656181A (en) * 1982-11-24 1987-04-07 Cermol S.A. Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same
US4500528A (en) * 1983-03-03 1985-02-19 Usv Pharmaceutical Corporation N-Substituted 1,4-dihydropyridines and pharmaceutical compositions
US4491582A (en) * 1983-03-03 1985-01-01 Usv Pharmaceutical Corporation N-(substituted piperazino)-1,4-dihydropyridine-3,5-carboxylic acid
US4435395A (en) 1983-03-03 1984-03-06 Usv Pharmaceutical Corporation N-Substituted 1,4-dihydropyridazines and pharmaceutical compositions
US4503223A (en) * 1983-08-11 1985-03-05 Usv Pharmaceutical Corporation Process for the purification of N-morpholinoalkyl dihydropyridines
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
US4757071A (en) * 1984-12-14 1988-07-12 Nisshin Flour Milling Co., Ltd. 1,4-dihydropyridine derivatives, and pharmaceutical compositions containing same, useful for treating cardiovascular diseases
US4833150A (en) * 1985-03-14 1989-05-23 Nelson Research & Development Co. 1,4-dihydropyridines
US4659717A (en) * 1985-08-21 1987-04-21 Eli Lilly And Company Dihydropyridines useful in the treatment of angina and stroke
DE3544211A1 (de) * 1985-12-13 1987-06-19 Bayer Ag Neue, fluorhaltige 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4780538A (en) * 1986-02-12 1988-10-25 Merck & Co., Inc. Process for 1,4-dihydropyridine compounds using a titanamine catalyst
US4849436A (en) * 1986-03-11 1989-07-18 Nelson Research & Development Co. 1,4-dihydropyridines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5170767A (en) * 1974-12-17 1976-06-18 Yamanouchi Pharma Co Ltd Shinki nn chikan 1*44 jihidoropirijinjudotaino goseiho

Also Published As

Publication number Publication date
PH15278A (en) 1982-11-02
DE3109794A1 (de) 1982-01-28
BE888327A (fr) 1981-10-08
LU83293A1 (fr) 1981-12-02
FR2480284B1 (enExample) 1984-01-06
FR2480284A1 (fr) 1981-10-16
IT1137539B (it) 1986-09-10
NZ196787A (en) 1984-04-27
CA1175825A (en) 1984-10-09
IL62362A (en) 1984-12-31
US4258042A (en) 1981-03-24
JPS56158762A (en) 1981-12-07
ZA81802B (en) 1982-02-24
AR227306A1 (es) 1982-10-15
AR229435A1 (es) 1983-08-15
GB2073739A (en) 1981-10-21
GB2073739B (en) 1984-07-11
ES8202001A1 (es) 1982-02-01
FI810981L (fi) 1981-10-12
ES499667A0 (es) 1982-02-01
NL8100745A (nl) 1981-11-02
SE8101211L (sv) 1981-10-12
IL62362A0 (en) 1981-05-20
CH647519A5 (de) 1985-01-31
AU6941181A (en) 1981-10-15
NO811240L (no) 1981-10-12
IT8121078A0 (it) 1981-04-10
DK162581A (da) 1981-10-12
ZW8281A1 (en) 1981-07-01

Similar Documents

Publication Publication Date Title
NO813659L (no) Trykkeinnretning.
FI802151A7 (fi) Verenpainetta alentavia amideja.
NO813103L (no) Gjenopplivningsapparat med trykkbelg.
IT1211037B (it) Dispositivo per la separazione di sangue.
ES266437Y (es) Abrazadera autoenganchable.
ATE10669T1 (de) Membranpumpe.
FI77044B (fi) Sidokedjade l-aspartyl-d-aminosyra- dipeptidsyror.
NO812604L (no) Perforeringsapparat.
FI842557L (fi) Tryckregulator.
FI811552A7 (fi) Moniejektori.
NO157370C (no) Pulversproeyte.
ATE15191T1 (de) Antihypertensiva.
ES267107Y (es) Segueta.
FI810981A7 (fi) Verenpainetta alentavia amiineja.
NO822635L (no) Flytende polytioetere.
FI814005A7 (fi) Fenoksialkoksisilaaneja.
FI73924B (fi) Loesbladspaerm.
BE888474A (fr) 1omega-hydroxy-2 beta-fluorocholecalciferol.
NO155073C (no) Trykkgiver.
NO154253C (no) Elektrokardiografisk anordning.
FI73532B (fi) Dubbelfrekvent stoeldbekaempningssystem.
FI812780A7 (fi) Bis-tetratsolimetyylitiolit.
FI834777L (fi) Pressanordning.
IT8124615A0 (it) Transduttore magnetoresistente.
ES282936Y (es) Manometro.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: USV PHARMACEUTICAL CORPORATION